1. Home
  2. ORIC vs PLSE Comparison

ORIC vs PLSE Comparison

Compare ORIC & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORIC
  • PLSE
  • Stock Information
  • Founded
  • ORIC 2014
  • PLSE 2014
  • Country
  • ORIC United States
  • PLSE United States
  • Employees
  • ORIC N/A
  • PLSE N/A
  • Industry
  • ORIC Biotechnology: Pharmaceutical Preparations
  • PLSE Medical/Dental Instruments
  • Sector
  • ORIC Health Care
  • PLSE Health Care
  • Exchange
  • ORIC Nasdaq
  • PLSE Nasdaq
  • Market Cap
  • ORIC 1.1B
  • PLSE 1.2B
  • IPO Year
  • ORIC 2020
  • PLSE 2016
  • Fundamental
  • Price
  • ORIC $11.54
  • PLSE $13.00
  • Analyst Decision
  • ORIC Strong Buy
  • PLSE Buy
  • Analyst Count
  • ORIC 11
  • PLSE 1
  • Target Price
  • ORIC $18.78
  • PLSE $22.00
  • AVG Volume (30 Days)
  • ORIC 1.1M
  • PLSE 171.4K
  • Earning Date
  • ORIC 11-13-2025
  • PLSE 11-05-2025
  • Dividend Yield
  • ORIC N/A
  • PLSE N/A
  • EPS Growth
  • ORIC N/A
  • PLSE N/A
  • EPS
  • ORIC N/A
  • PLSE N/A
  • Revenue
  • ORIC N/A
  • PLSE $86,000.00
  • Revenue This Year
  • ORIC N/A
  • PLSE N/A
  • Revenue Next Year
  • ORIC N/A
  • PLSE $700.00
  • P/E Ratio
  • ORIC N/A
  • PLSE N/A
  • Revenue Growth
  • ORIC N/A
  • PLSE N/A
  • 52 Week Low
  • ORIC $3.90
  • PLSE $12.56
  • 52 Week High
  • ORIC $14.93
  • PLSE $25.00
  • Technical
  • Relative Strength Index (RSI)
  • ORIC 40.39
  • PLSE 25.93
  • Support Level
  • ORIC $11.28
  • PLSE $12.56
  • Resistance Level
  • ORIC $12.50
  • PLSE $14.00
  • Average True Range (ATR)
  • ORIC 0.82
  • PLSE 0.94
  • MACD
  • ORIC -0.16
  • PLSE -0.27
  • Stochastic Oscillator
  • ORIC 22.22
  • PLSE 11.40

About ORIC Oric Pharmaceuticals Inc.

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.

Share on Social Networks: